Omthera (OMTH) rockets 99% to $13.50 following news that AstraZeneca (AZN) has agreed to acquire the heart-drug company for up to $443M. The upfront payment of $323M is worth $12.70 a share, while a secondary contingent payment of $120M is worth $4.70. AstraZeneca is +2.4%.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs